BioSpace News Archive

Business

Vyant Bio, Inc., Ordaōs Bio, and Cellaria, Inc. Announce Collaboration to Design and Qualify Biomarker-Specific Small Protein Therapeutics

New collaboration mitigates risk in drug d iscovery process with artificial intelligence and in vitro “avatar” clinical trials

April 22, 2021
·
8 min read
RB Capital Increases Investment in Sunshine Biopharma

Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that RB Capital has injected an additional investment of $500,000 to augment the Company’s Coronavirus drug development program.

April 22, 2021
·
4 min read
Business

OPKO Health to Report First Quarter 2021 Financial Results on April 28, 2021

OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2021, as well as discuss financial guidance, after the close of the U.S. financial markets on Wednesday, April 28, 2021.

April 22, 2021
·
1 min read
BioMidwest

Ocuphire’s APX3330 for Retinal Diseases to be Presented at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Virtual Annual Meeting

Oral Administration of APX3330 Reduced Neovascularization in a Pre-Clinical Mouse Model of Laser-Induced Choroidal Neovascularization New Data from Physiological-Based Pharmacokinetic (PBPK) Model Supports APX3330 Oral Dose for the Ongoing ZETA-1 Phase 2 Trial

April 22, 2021
·
5 min read
Nearly half a million dollars to fund a research chair to ensure food safety and quality

In the food industry, the control of microbes, such as bacteria or viruses, often requires the addition of synthetic chemicals. Yet consumer demand for natural antimicrobial products is growing.

April 22, 2021
·
4 min read
Business

Eric Schmidt appointed incoming Chair of the Broad Institute Board of Directors

The Broad Institute of MIT and Harvard announced that renowned technologist, entrepreneur and philanthropist Eric Schmidt will become the next Chair of the Board of Directors, succeeding Louis V. Gerstner, Jr., who has served as Chair of the Board since 2013.

April 22, 2021
·
6 min read
Biotech Bay

DiaCarta’s Novel XNA Technology Rapidly Detects Raging New SARS-CoV-2 Variants

DiaCarta Inc., a precision molecular diagnostics company and leading developer of novel oncology tests using liquid biopsy today announced the publication of a study entitled “A Rapid SARS-CoV-2 Variant Detection by Molecular-Clamping Based RT-qPCR” in MedRxiV (https://doi.org/10.1101/2021.04.01.21254484)

April 22, 2021
·
3 min read
Pharm Country

IBM Study: COVID-19 Pandemic Impacted 9 in 10 Surveyed Consumers’ Views on Sustainability

The COVID-19 pandemic has elevated consumers’ focus on sustainability and willingness to pay out of their own pockets – or even take a pay cut – for a sustainable future, according to a new IBM Institute for Business Value survey of over 14,000 consumers in nine countries.

April 22, 2021
·
4 min read
Business

Vertex and Obsidian Therapeutics Establish Collaboration to Discover Novel Therapies That Regulate Gene Editing

Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) and Obsidian Therapeutics announced today that the two companies have entered into a strategic research collaboration and licensing agreement focused on the discovery of novel therapies that regulate gene editing for the treatment of serious diseases.

April 22, 2021
·
6 min read
Business

Lumen Bioscience Announces Appointment of Marcos Milla, Ph.D. to Board of Directors & Expansion of Leadership Team

Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today announced the appointment of Marcos Milla, Ph.D., to the company’s board of directors and the expansion of its leadership team

April 22, 2021
·
3 min read